U.S. Patent Disclosures
• Stem Cell Therapeutics Corp., of Calgary, Alberta, said it received U.S. Patent No. 7,994,131, titled "Stimulation of Proliferation of Pluripotent Stem Cells through Administration of Pregnancy Associated Compounds." It relates to the use of human chorionic gonadotropin to treat patients presenting with damaged or diseased heart cells.
• Trophos SA, of Marseille, France, was granted U.S. Patent No.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter